Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Projected to Release Earnings on Monday

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) is anticipated to announce its resultson Monday, July 27th. Analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post earnings of $0.18 per share and revenue of $970.6930 million for the quarter.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. The business had revenue of $881.71 million during the quarter, compared to the consensus estimate of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%. On average, analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shionogi & Co., Ltd. Unsponsored ADR stock opened at $8.68 on Friday. The firm has a market capitalization of $14.77 billion, a P/E ratio of 10.85, a PEG ratio of 3.37 and a beta of 0.09. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The business has a 50-day moving average of $8.86 and a 200-day moving average of $9.88. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SGIOY. Jefferies Financial Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Finally, The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy”.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.